ArticleCellular & molecular immunology2019

In drug-induced, immune-mediated hepatitis, interleukin-33 reduces hepatitis and improves survival independently and as a consequence of FoxP3+ T-cell activity.

Merylin Cottagiri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.